Literature DB >> 34035377

Low serum adiponectin level is associated with better physical health-related quality of life in chronic kidney disease.

Ji Hye Kim1, Ji Min Han2, Hyang Kim1, Kyu-Beck Lee1, Wookyung Chung3, Yong-Soo Kim4, Sue K Park5, Dong Wan Chae6, Curie Ahn7, Kook-Hwan Oh7, Young Youl Hyun8.   

Abstract

Hyperadiponectemia is paradoxically associated with renal disease progression and mortality in chronic kidney disease (CKD). Its association with health-related quality of life (HR-QOL) is unknown. This study aimed to verify the association between adiponectin and HR-QOL in Korean pre-dialysis CKD cohort. This cross-sectional study analyzed 1551 pre-dialysis CKD patients from KNOW-CKD (KoreaN Cohort Study for Outcome in Patients With Chronic Kidney Disease). Participants were categorized into three tertiles (T1-T3) according to adiponectin levels. HR-QOL was assessed using SF-36. High physical component summary (PCS) and mental component summary (MCS) were defined as highest quartile of each score. Multivariate logistic regression was used to analyze odds ratio (OR) and 95% confidence interval (CI) for high PCS and MCS. Prevalence of high PCS were 33.3%, 27.5%, and 17.0% and that of high MCS were 31.7%, 24.8%, and 21.3% for T1, T2, and T3 (both p for trend < 0.001). The adjusted OR [95% CI] of T1 and T2 in reference to T3 were 1.56 [1.09-2.23] and 1.19 [0.85-1.68] for high PCS and 1.19 [0.85-1.68] and 0.94 [0.68-1.29] for high MCS. Serum adiponectin level was inversely associated with physical HR-QOL in Korean pre-dialysis CKD patients. This relationship was independent of various cardiovascular risk factors.

Entities:  

Year:  2021        PMID: 34035377     DOI: 10.1038/s41598-021-90339-8

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  39 in total

Review 1.  Health-related quality of life in different stages of renal failure.

Authors:  Marina Avramovic; Vladisav Stefanovic
Journal:  Artif Organs       Date:  2012-03-16       Impact factor: 3.094

Review 2.  Adiponectin: mechanistic insights and clinical implications.

Authors:  A T Turer; P E Scherer
Journal:  Diabetologia       Date:  2012-06-12       Impact factor: 10.122

Review 3.  The Relationship Between Chronic Kidney Disease, Symptoms and Health-Related Quality of Life: A Systematic Review.

Authors:  Harith Eranga Yapa; Louise Purtell; Shirley Chambers; Ann Bonner
Journal:  J Ren Care       Date:  2019-11-03

Review 4.  Adiponectin, cardiovascular disease, chronic kidney disease: emerging data on complex interactions.

Authors:  Megan M Lo; Mark Mitsnefes
Journal:  Pediatr Nephrol       Date:  2011-02-21       Impact factor: 3.714

5.  Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study.

Authors:  Bjoern Becker; Florian Kronenberg; Jan T Kielstein; Hermann Haller; Christian Morath; Eberhard Ritz; Danilo Fliser
Journal:  J Am Soc Nephrol       Date:  2005-03-02       Impact factor: 10.121

Review 6.  Adiponectin: key role and potential target to reverse energy wasting in chronic heart failure.

Authors:  An M Van Berendoncks; Anne Garnier; Renée Ventura-Clapier; Viviane M Conraads
Journal:  Heart Fail Rev       Date:  2013-09       Impact factor: 4.214

Review 7.  Adipocytokines in relation to cardiovascular disease.

Authors:  Johan Van de Voorde; Bart Pauwels; Charlotte Boydens; Kelly Decaluwé
Journal:  Metabolism       Date:  2013-07-15       Impact factor: 8.694

Review 8.  Adiponectin and chronic kidney disease; a review on recent findings.

Authors:  Maryam Heidari; Parto Nasri; Hamid Nasri
Journal:  J Nephropharmacol       Date:  2015-07-27

9.  Plasma adiponectin levels and type 2 diabetes risk: a nested case-control study in a Chinese population and an updated meta-analysis.

Authors:  Yeli Wang; Rui-Wei Meng; Setor K Kunutsor; Rajiv Chowdhury; Jian-Min Yuan; Woon-Puay Koh; An Pan
Journal:  Sci Rep       Date:  2018-01-10       Impact factor: 4.379

10.  The Adiponectin Paradox for All-Cause and Cardiovascular Mortality.

Authors:  Claudia Menzaghi; Vincenzo Trischitta
Journal:  Diabetes       Date:  2018-01       Impact factor: 9.461

View more
  2 in total

1.  Association of High Serum Adiponectin Level With Adverse Cardiovascular Outcomes and Progression of Coronary Artery Calcification in Patients With Pre-dialysis Chronic Kidney Disease.

Authors:  Sang Heon Suh; Tae Ryom Oh; Hong Sang Choi; Chang Seong Kim; Joongyub Lee; Yun Kyu Oh; Ji Yong Jung; Kyu-Beck Lee; Kook-Hwan Oh; Seong Kwon Ma; Eun Hui Bae; Soo Wan Kim
Journal:  Front Cardiovasc Med       Date:  2022-01-13

2.  Decreased Adiponectin Levels Are a Risk Factor for Cognitive Decline in Spinal Cord Injury.

Authors:  Fan-Jie Liu; Hong-Hao Xu; Ying Yin; Yuan-Zhen Chen; Liang-Yu Xie; Hua-Zhong Li; Dan-Dan Wang; Bin Shi
Journal:  Dis Markers       Date:  2022-01-17       Impact factor: 3.434

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.